Frier Levitt, LLC

What Frier Levitt, LLC does

Frier Levitt, LLC is a national boutique law firm founded in 2000 by Daniel B. Frier and Jonathan E. Levitt, headquartered in Pine Brook, New Jersey with a regional office at One World Trade Center in New York City. The firm is exclusively focused on the healthcare, life sciences, and pharmacy industries, providing regulatory, transactional, and litigation counsel across more than a dozen specialized practice areas. Core offerings include 340B Drug Pricing Program services, PBM audit and network-contracting representation, FDA and DEA regulatory compliance, government investigations and False Claims Act defense, healthcare M&A and private equity advisory, employment law for healthcare entities, digital health counsel, and a newly launched cannabis/hemp/psychedelics practice. The firm also produces ongoing thought leadership through articles, CLE webinars, and conference participation at industry events such as the 340B Coalition, ASHP, NASP, and Community Oncology Alliance meetings.

The firm serves enterprise clients across healthcare providers (hospitals, health systems, large physician group practices, ambulatory surgery centers, laboratories), pharmacy providers (chain, community, compounding, specialty, long-term care, fertility, home infusion), life sciences and pharmaceutical companies (manufacturers, wholesalers, GPOs, PSAOs), private equity and venture capital investors, and plan sponsors and payers. Notable engagements include federal litigation against CVS Health alleging $250 million in diverted 340B savings on behalf of Mount Sinai, University of Kansas, and University of Michigan Health Systems. With 50+ attorneys — many of whom hold dual credentials as licensed healthcare professionals including pharmacists, podiatrists, hospital administrators, clinicians, and medical billing coders — Frier Levitt combines legal expertise with operational and clinical insight.

Revenue is generated through professional services fees billed on a per-matter basis under quote-based, multi-year engagement structures. The firm employs a sales-led go-to-market motion centered on direct attorney-client relationships, professional referrals, and thought leadership, supported by a content-driven marketing program across its website, LinkedIn, X, YouTube, Instagram, and email newsletter channels. It maintains a national service footprint through attorney admissions in 13+ jurisdictions, enabling cross-state healthcare M&A and litigation mandates. The firm has no parent company, no external institutional investors, and no disclosed funding rounds, operating as an independent limited liability company governed under New Jersey law.

Name

Frier Levitt, LLC

Legal name

Frier & Levitt, LLC

Website

https://frierlevitt.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Frier Levitt is a national boutique law firm exclusively serving healthcare, life sciences, and pharmacy clients with 50+ attorneys, many dually licensed as healthcare professionals. It delivers regulatory, transactional, and litigation counsel from offices in New Jersey and New York.

Ownership category

akta.pro rank

Product category

Healthcare Legal Services

NAICS

Offices of Lawyers (541110)

SIC

Services-Legal Services (8111)

akta.pro primary industry

Litigation & Dispute Resolution (BPAHAAAB)

Keywords

• Healthcare legal services
• Pharmacy regulatory law
• 340B drug pricing
• FDA regulatory compliance
• Healthcare M&A advisory

Headquarters

HQ city

Pine Brook

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Legal Services: The firm generates revenue through legal fees for regulatory, transactional, and litigation counsel provided to healthcare, life sciences, and pharmacy clients. Services include advocacy, government affairs, regulatory compliance, healthcare litigation, employment, intellectual property, and M&A advisory.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels9 records

Core offering

Frier Levitt is a national boutique law firm exclusively serving the healthcare, life sciences, and pharmacy industries. The firm provides regulatory, transactional, and litigation legal counsel covering 340B Drug Pricing Program compliance, PBM audits and disputes, FDA regulatory matters, M&A and private equity transactions, government investigations defense, HIPAA compliance, Stark Law and Anti-Kickback Statute matters, employment law, and digital health advisory work. Services are delivered through direct attorney-client engagements by 50+ attorneys, many of whom are also licensed healthcare professionals.

Product overview

Frier Levitt is a national boutique law firm exclusively focused on healthcare, life sciences, and pharmacy industries. The firm offers a comprehensive suite of legal services organized around two primary practice areas: Healthcare Legal Services and Life Sciences & Pharmacy Legal Services. Core specialized offerings include 340B Drug Pricing Program services, PBM audits and network contracting, FDA regulatory compliance, digital health counsel, private equity/M&A transactions, government investigations defense, HIPAA compliance, and employment law for healthcare entities. The firm also provides educational webinars and industry publications to clients. With offices in New Jersey and New York and over 50 attorneys, many of whom are licensed healthcare professionals, the firm delivers regulatory, transactional, and litigation counsel to providers, pharmacies, manufacturers, and investors across the country.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Achieved 'full global resolution' for clients in government investigations at earliest stage possible, addressing collateral consequences to professional licenses.
• +2 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Health Law AllianceminorStrategic or Co-development Partner · 20 January 2026Dr. Martha M. Rumore, a pharmacist-attorney with over two decades of experience in FDA, DEA, and pharmaceutical regulatory matters, joined Health Law Alliance as Of Counsel. She previously served for six years as Senior Counsel at Frier Levitt in Manhattan. This represents a professional affiliation rather than a formal commercial partnership.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Hogan Lovells: Global law firm with significant healthcare and life sciences regulatory and litigation capabilities — directly competes with Frier Levitt on FDA, DEA, and 340B matters for major hospital and pharma clients.
• King & Spalding: Am Law firm with a strong healthcare and life sciences practice including FDA regulatory, government investigations, and healthcare transactions — overlaps with Frier Levitt's False Claims Act and pharma regulatory work.
• McDermott Will & Emery: Am Law 100 firm with one of the largest dedicated healthcare practices in the U.S., serving providers, payers, and life sciences companies across regulatory, transactional, and litigation matters — a key broad incumbent competitor to Frier Levitt's healthcare boutique model.
• Ropes & Gray: Elite Am Law firm with a leading healthcare and life sciences practice covering M&A, regulatory, and litigation — competes for high-end healthcare PE deals and life sciences mandates.
• Foley & Lardner: Am Law 100 firm with a substantial healthcare and life sciences industry team covering regulatory, M&A, and IP — competes with Frier Levitt on healthcare transactions and FDA regulatory matters.
• Nelson Mullins Riley & Scarborough: Am Law firm with a sizable healthcare practice covering regulatory, litigation, and transactional work for providers, health systems, and life sciences companies — competes in similar healthcare specialty segments.

Direct peers

• Epstein Becker Green: National healthcare-focused law firm with deep FDA, healthcare regulatory, and litigation capabilities serving providers and life sciences clients — a directly comparable boutique-to-mid-size competitor with similar practice mix.
• Akerman LLP: Mid-size law firm with one of the largest healthcare practices in the U.S., covering providers, payers, and life sciences across regulatory and litigation matters — a directly comparable specialty competitor.
• Hall Render Killian Heath & Lyman: Largest healthcare-focused law firm in the U.S., with nationally recognized healthcare regulatory, transactional, and litigation practices serving hospitals, health systems, and physician groups — the most direct large-scale competitor in the healthcare boutique space.

Emerging players

• Health Law Alliance: Healthcare-focused boutique law firm competing for pharmacy, PBM, and 340B regulatory and litigation work; notably absorbed former Frier Levitt senior counsel Dr. Martha Rumore in 2026, signaling direct competition for specialty talent.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/frierlevitt
• YouTubeyoutube.com/channel/UCmNj89tlz1wZS-MFjoPf21A
• LinkedInlinkedin.com/company/2341486
• Instagraminstagram.com/frierlevitt
• Facebookfacebook.com/frierlevittattorneys

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Frier Levitt, LLC